Stephens & Co. Initiates Coverage On TransMedics Gr with Overweight Rating, Announces Price Target of $151
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. has initiated coverage on TransMedics Group (NASDAQ:TMDX) with an Overweight rating and a price target of $151.
June 04, 2024 | 9:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. has initiated coverage on TransMedics Group with an Overweight rating and a price target of $151, indicating a positive outlook for the stock.
The initiation of coverage with an Overweight rating and a high price target suggests that the analyst expects the stock to perform well. This is likely to generate positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100